Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Brigatinib has emerged as a cornerstone in the treatment of specific lung cancers, particularly non-small cell lung cancer (NSCLC) with ALK gene alterations. Its efficacy as a targeted therapy is well-documented, and its role as a high-purity pharmaceutical intermediate is critical for the production of life-saving medications. As a leading pharmaceutical intermediate supplier based in China, we are committed to providing the essential building blocks for such advanced treatments.
The therapeutic power of Brigatinib lies in its potent dual inhibition of ALK and EGFR pathways, which are often dysregulated in ALK-positive NSCLC. By precisely targeting these molecular drivers, Brigatinib effectively halts cancer cell proliferation, offering a significant advantage over traditional chemotherapy. The pharmaceutical industry relies on a consistent supply of high-quality APIs like Brigatinib to develop and manufacture these targeted therapies. Our role as a supplier ensures that this vital intermediate is readily available to meet the growing demand in the oncology sector.
We specialize in providing Brigatinib API with exceptional purity, exceeding 98%, and adhering to strict pharmaceutical-grade standards. Available in a convenient powder form with a two-year shelf life, our product is designed to meet the rigorous demands of pharmaceutical manufacturing and research. Sourcing this key intermediate from China offers a strategic advantage, combining quality with cost-effectiveness. We understand the critical nature of our role in the supply chain and are dedicated to maintaining the integrity and reliability of our products.
The applications for Brigatinib API extend beyond its current therapeutic indications. It serves as a valuable component for ongoing research, exploring new treatment modalities and combination therapies for various cancers. As a trusted supplier of ALK inhibitor pharmaceutical intermediates, we empower our clients to drive innovation in targeted oncology. Our commitment is to facilitate the advancement of cancer care by providing the highest quality pharmaceutical ingredients, thereby contributing to better patient outcomes globally.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
